Amneal Aims To Bolster Generics Margins

As Company Aims To Deliver Six To Seven High-Value Products Annually

 
• By Akriti Seth
  
growth
After seeing a 11% drop in generics revenue in Q1 2021, Amneal aims to improve its generics margins • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business